How should a sessile colonic polyp be managed?

Management of Sessile Colonic Polyps

The management of sessile colonic polyps depends primarily on size: cold snare polypectomy for polyps 3-19 mm, and endoscopic mucosal resection (EMR) for polyps ≥20 mm, with technique selection based on polyp morphology, location, and endoscopist expertise. 1

Size-Based Management Algorithm

Small Sessile Polyps (3-9 mm)

• Cold snare polypectomy is the preferred technique, offering superior safety with decreased delayed bleeding and perforation risk compared to hot snare methods 1
• Cold snare achieves high complete resection rates (residual adenoma rate 0.98%) with sufficient depth including muscularis mucosa 1
• Dedicated cold snares (0.3 mm wire, 9 mm diameter) show higher complete resection rates (91% vs 79%) compared to conventional snares 1

Medium Sessile Polyps (10-19 mm)

• Cold or hot snare polypectomy (with or without submucosal injection) is recommended 1
• EMR should be strongly considered for non-polypoid and serrated lesions in this size range, as conventional polypectomy shows 31% incomplete resection rates for proximal serrated lesions, compared to only 3.6% recurrence with EMR 1
• The indistinct borders and difficult tissue capture of serrated lesions make EMR technically superior 1

Large Sessile Polyps (≥20 mm)

• EMR is the preferred treatment method to avoid the higher morbidity, mortality, and cost of surgical alternatives 1
• An endoscopist experienced in advanced polypectomy should perform these resections 1
• Complete resection should be achieved in a single session using the safest minimum number of pieces, as prior failed attempts significantly increase recurrence risk 1

Technical Considerations for EMR

Submucosal Injection Solutions

• Use viscous injection solutions (hydroxyethyl starch, succinylated gelatin) rather than normal saline for polyps ≥20 mm 1
• Gelofusin provides longer-lasting lift (mean 36 minutes vs 12 minutes with saline) and reduces piecemeal resection pieces needed 1
• Add contrast agents (indigo carmine or methylene blue) to facilitate layer recognition 1
• Avoid tattoo with carbon particle suspension as submucosal injectate, as it causes fibrosis that compromises future resection attempts 1
• Low concentration adrenaline should be included in the injection solution 1

Resection Technique

• Use carbon dioxide insufflation during the procedure 1
• Avoid pure cutting or prolonged pure coagulation current 1
• Piecemeal resection may be preferable for larger and/or proximal lesions 1
• Non-lifting lesions should not undergo conventional snare polypectomy as this indicates possible submucosal invasion or fibrosis 1
• Perform careful post-procedure inspection with photographic documentation 1
• Tattoo the resection site according to local policy 1

Cold Snare EMR for Large Polyps

Cold snare piecemeal EMR (CSP-EMR) is emerging as a safe alternative for sessile polyps ≥20 mm, with low recurrence rates (5.5% at first surveillance, 3.5% at second surveillance) and minimal adverse events 1, 2

• Intraprocedural bleeding occurs in only 2.2% of cases 2
• Post-EMR bleeding is self-limited in 3.8% of patients 2
• Perforation risk is extremely low (0.5%) 2
• This technique eliminates electrocautery-related complications while maintaining efficacy 1, 2

Surveillance and Follow-Up

• Check the resection site 2-6 months after piecemeal EMR 1
• Positively identify, photograph, and assess the scar using image enhancement techniques 1
• Target recurrence rates: <10% at 12 months (minimum standard), <5% (aspirational standard) 1
• Provide patients with written information about post-procedure complications, recommended actions, and emergency contact numbers 1

Performance Standards

Key quality metrics for large non-pedunculated polyp management include: 1

• EMR perforation rate: <2% (minimum), <0.5% (aspirational)
• EMR post-procedure bleeding rate: <5%
• Time from diagnosis to definitive therapy: <4 weeks
• Time from referral to treatment: <8 weeks

Special Considerations

High-Risk Features Requiring Surgical Referral

Refer to surgery when: 1

• Endoscopic features suggest submucosal invasion (depressed morphology, ulceration, fold convergence)
• Non-lifting sign after submucosal injection
• Prior failed resection attempts (except unifocal, diminutive residual adenoma)
• Location within inflamed colitis segment
• Lesions involving appendiceal orifice, diverticulum, or dentate line

Increased Risk Situations

Exercise additional caution with: 1

• Cecal location
• Size ≥40 mm
• Endoscopist inexperience
• Difficult locations (behind flexures/folds, stenotic diverticular disease)

Endoscopic Submucosal Dissection (ESD)

ESD has limited indications even at experienced centers, reserved for: 1

• Large lesions (>20 mm) with suspected submucosal invasion
• Mucosal lesions with severe fibrosis
• Local residual early carcinoma after prior endoscopic resection
• Non-polypoid dysplasia in inflammatory bowel disease
• Most benign colorectal neoplasms can be adequately managed with piecemeal EMR 1